ESMO 2022 Conference Coverage


 

Sotorasib vs. Docetaxel for Previously Treated NSCLC With KRAS G12C Mutation: CodeBreaK 200 Phase III Study

737 views
December 30, 2022
Comments 0
Login to view comments. Click here to Login